Proline

The dosage of Proline is almost always determined by the total protein requirements of the patient rather than as a standalone dose.

Parenteral Nutrition

In a clinical setting, the standard adult dose for amino acids (including Proline) typically ranges from 0.8 to 2.0 grams per kilogram of body weight per day. For a 70 kg adult, this translates to roughly 56 to 140 grams of total amino acids daily. Proline usually constitutes about 4% to 8% of these formulations. Your healthcare provider will calculate the exact amount based on your metabolic rate, the severity of your illness, and your renal function.

Oral Supplementation (Off-label/Nutritional)

When used as a dietary supplement for tissue support, common dosages range from 500 mg to 3,000 mg per day, usually divided into two or three doses. However, clinical data on the efficacy of oral Proline as a standalone therapy is limited compared to its use in IV nutrition.

Pediatric requirements for amino acids are significantly higher than adult requirements due to the demands of growth and development.

Neonates and Infants

For infants receiving TPN, the amino acid dosage may range from 2.5 to 3.5 grams per kilogram per day. Specialized pediatric formulations (like TrophAmine) contain Proline levels tailored to the neonatal liver's metabolic capacity.

Children and Adolescents

Dosage is scaled based on weight and age, typically ranging from 1.5 to 2.5 grams per kilogram per day. Use in children must be strictly monitored by a pediatrician to avoid hyperammonemia (excess ammonia in the blood).

Renal Impairment

In patients with chronic kidney disease (CKD) or acute kidney injury (AKI), the administration of nitrogen-rich substances like Proline must be handled with extreme caution. High doses can lead to an accumulation of blood urea nitrogen (BUN). Healthcare providers may reduce the total amino acid load or use specialized 'renal' formulations that prioritize essential amino acids over non-essential ones like Proline.

Hepatic Impairment

Patients with severe liver cirrhosis or hepatic encephalopathy may have difficulty processing amino acids, leading to an imbalance in plasma levels. Dosing should be individualized, and patients should be monitored for signs of worsening neurological function.

Elderly Patients

No specific dosage adjustment is required for age alone; however, because elderly patients are more likely to have decreased renal clearance, a more conservative starting dose is often recommended.

Intravenous Administration

Proline infusions are administered through a central venous catheter or a peripheral IV line, depending on the concentration of the solution. These infusions are typically delivered continuously over 12 to 24 hours to ensure steady metabolic utilization.

Oral Administration

If taking Proline capsules, it is generally recommended to take them on an empty stomach (at least 30 minutes before or 2 hours after a meal) to minimize competition with other dietary amino acids for absorption. Swallow the capsules whole with a full glass of water.

Storage

• IV Solutions: Store at room temperature (20°C to 25°C) and protect from light. Do not freeze. If the solution is cloudy or contains particles, it must be discarded.
• Oral Supplements: Keep in a cool, dry place away from direct sunlight.

In a hospital setting, a missed dose of a TPN infusion will be managed by the nursing staff. Do not attempt to 'double up' the infusion rate to catch up. For oral supplements, if you miss a dose, take it as soon as you remember. If it is almost time for your next dose, skip the missed dose and resume your regular schedule.

An overdose of Proline, particularly through IV administration, can lead to Amino Acid Toxicity. Symptoms include:

• Nausea and vomiting
• Flushing of the skin
• Metabolic acidosis (excess acid in the body)
• Azotemia (high levels of nitrogen in the blood)

In the event of a suspected overdose, the infusion should be stopped immediately, and the patient's electrolyte and acid-base status should be evaluated in an emergency department.

> Important: Follow your healthcare provider's dosing instructions. Do not adjust your dose without medical guidance.

When administered as part of a balanced amino acid infusion, Proline is generally well-tolerated because it is a naturally occurring substance. However, some patients may experience:

• Injection Site Reactions: Redness, swelling, or a slight burning sensation at the site of the IV insertion. This usually resolves shortly after the infusion rate is adjusted.
• Flushing: A temporary feeling of warmth or redness in the face and neck, often occurring if the infusion is administered too rapidly.
• Nausea: A mild feeling of stomach upset, which typically dissipates as the body adjusts to the nutrient load.

• Diaphoresis: Increased sweating, often linked to the thermic effect of protein metabolism.
• Headache: Mild to moderate tension-type headaches.
• Dizziness: A brief sensation of lightheadedness, particularly when moving from a sitting to a standing position during the infusion.

• Hyperammonemia: An elevation of ammonia levels in the blood, which can cause confusion or lethargy. This is more common in patients with underlying urea cycle disorders.
• Metabolic Acidosis: A disruption of the body's pH balance, characterized by rapid breathing and fatigue.
• Urticaria: A skin rash or hives, which may indicate a sensitivity to one of the components in the multi-amino acid solution.

> Warning: Stop taking Proline and call your doctor immediately if you experience any of these.

• Anaphylaxis: Although extremely rare for pure Proline, allergenic extracts containing Proline can cause severe allergic reactions. Symptoms include difficulty breathing, swelling of the throat, or a rapid drop in blood pressure.
• Pulmonary Edema: Shortness of breath or a persistent cough, which may indicate fluid overload from the IV infusion.
• Hepatotoxicity: Yellowing of the eyes or skin (jaundice), dark urine, or upper right abdominal pain. This is a risk with long-term TPN use (TPN-associated liver disease).
• Severe Confusion or Tremors: These may be signs of nitrogen buildup affecting the brain (encephalopathy).

Chronic administration of Proline through parenteral nutrition can lead to specific long-term complications:

• Aluminum Toxicity: Some amino acid injections contain trace amounts of aluminum, which can accumulate in the bones and brain over months or years, especially in patients with kidney impairment.
• Essential Fatty Acid Deficiency: If Proline and other amino acids are given without adequate lipid emulsions, the patient may develop skin rashes and impaired healing.
• Bone Demineralization: Long-term TPN can sometimes affect calcium and phosphorus balance, leading to weakened bones.

No FDA black box warnings exist specifically for L-Proline. However, many amino acid injections used to deliver Proline carry a warning regarding Aluminum Toxicity in Neonates.

Summary of Warning: This product contains aluminum that may be toxic. Aluminum may reach toxic levels with prolonged parenteral administration if kidney function is impaired. Premature neonates are particularly at risk because their kidneys are immature, and they require large amounts of calcium and phosphate solutions, which also contain aluminum. Research indicates that patients with impaired kidney function, including premature neonates, who receive parenteral levels of aluminum at greater than 4 to 5 mcg/kg/day accumulate aluminum at levels associated with central nervous system and bone toxicity. Tissue loading may occur at even lower rates of administration.

Report any unusual symptoms to your healthcare provider.

Proline is a metabolic building block, but its administration in concentrated pharmaceutical forms requires careful medical oversight. It should never be used as a substitute for a balanced diet unless medically necessary. Patients with rare genetic metabolic disorders must be screened before receiving high doses of Proline.

As noted in the side effects section, there are no standalone black box warnings for Proline. However, the FDA requires a warning on all large-volume parenterals (including those containing Proline) regarding the risk of Aluminum Toxicity, particularly in premature infants and those with renal impairment. Healthcare providers must monitor the total aluminum load from all IV sources.

Allergic Reactions / Anaphylaxis Risk

While Proline itself is rarely an allergen, it is frequently used as a stabilizer in Standardized Insect Venom Allergenic Extracts. Patients undergoing allergy shots should be monitored for at least 30 minutes post-injection for signs of systemic allergic reactions. If you have a known hypersensitivity to any amino acid products, inform your doctor immediately.

Hyperprolinemia

Patients with Hyperprolinemia Type I or II (genetic deficiencies in Proline-degrading enzymes) should not receive Proline supplements or high-protein infusions. In these individuals, Proline levels can reach toxic concentrations in the blood, potentially leading to seizures or intellectual disabilities.

Fluid and Electrolyte Balance

Administering Proline via IV can cause shifts in fluid and electrolytes. This is a major concern for patients with Congestive Heart Failure (CHF) or Pulmonary Edema. Healthcare providers must balance the nutritional benefits against the risk of fluid overload.

Nitrogen Accumulation

In patients with impaired urea cycle function, the nitrogen provided by Proline cannot be safely converted to urea for excretion. This can lead to life-threatening ammonia toxicity. Regular monitoring of blood ammonia levels is required in high-risk patients.

If you are receiving Proline as part of long-term therapy, your healthcare provider will perform regular tests, including:

• Serum Electrolytes: Sodium, potassium, chloride, and bicarbonate levels.
• Renal Function Tests: Blood Urea Nitrogen (BUN) and Serum Creatinine.
• Liver Function Tests (LFTs): ALT, AST, and Bilirubin to check for TPN-related liver stress.
• Blood Glucose: Amino acid infusions can sometimes affect insulin sensitivity and blood sugar levels.

Proline does not typically cause sedation or cognitive impairment. However, if you experience dizziness or confusion during or after an infusion, do not drive or operate heavy machinery until these symptoms have completely resolved.

Alcohol should be avoided while receiving amino acid therapy. Alcohol can stress the liver and interfere with the body's ability to process nitrogen and synthesize proteins, potentially negating the benefits of Proline therapy.

Intravenous Proline (as part of TPN) should not be stopped abruptly. Sudden discontinuation can cause 'rebound hypoglycemia' (a sharp drop in blood sugar) because the body has adjusted its insulin production to the continuous nutrient load. The infusion rate is typically tapered down over several hours.

> Important: Discuss all your medical conditions with your healthcare provider before starting Proline.

There are no drugs that are strictly contraindicated with Proline due to a direct chemical reaction. However, Proline should not be added to IV solutions containing Calcium Gluconate or Phosphate without careful compatibility checking, as this can cause the formation of precipitates (solid particles) that are dangerous if infused into the bloodstream.

Corticosteroids (e.g., Prednisone, Dexamethasone)

Corticosteroids promote protein breakdown (catabolism). Taking these medications while receiving Proline for nitrogen balance may reduce the effectiveness of the amino acid therapy. Your doctor may need to increase the amino acid dosage to compensate for the steroid-induced catabolism.

Tetracycline Antibiotics

Tetracyclines can have an anti-anabolic effect, which may interfere with the protein-sparing benefits of amino acid infusions. Monitoring of BUN levels is recommended when these drugs are used together.

Diuretics (e.g., Furosemide, Hydrochlorothiazide)

Diuretics can alter the excretion of electrolytes and nitrogenous waste. Since Proline therapy involves a nitrogen load, the combination may require more frequent monitoring of kidney function and fluid status.

Other Amino Acid Supplements

Taking high doses of other amino acids, such as L-Arginine or L-Lysine, concurrently with Proline can lead to competition for transport across the gut lining or the blood-brain barrier. This may result in an imbalance where one amino acid is absorbed at the expense of others.

High-Protein Diets

If you are taking oral Proline supplements, a diet extremely high in protein may decrease the supplement's absorption due to competition for transporters. Conversely, a protein-deficient diet may increase the body's sensitivity to Proline.

Dairy Products

Calcium in dairy may theoretically interact with Proline's chelating properties, though this is rarely clinically significant for patients with a normal diet.

Vitamin C (Ascorbic Acid)

Vitamin C is a necessary cofactor for the enzyme that converts Proline into hydroxyproline. While not a negative interaction, a deficiency in Vitamin C will make Proline therapy less effective for collagen synthesis and wound healing. Most clinicians ensure Vitamin C is included in the patient's nutritional regimen.

St. John's Wort

While there is no direct metabolic interaction, St. John's Wort can affect the metabolism of many drugs. Its impact on the specialized transporters used by amino acids is not well-studied, so caution is advised.

Proline administration can affect the results of several laboratory tests:

• Blood Urea Nitrogen (BUN): May be elevated due to increased nitrogen intake.
• Urinary Amino Acid Screen: Will show elevated Proline levels, which could be misinterpreted as a metabolic disorder if the lab is unaware of the supplementation.
• Serum Ammonia: May be elevated in patients with liver dysfunction.

> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking.

Proline must NEVER be used in the following circumstances:

1. 1Hyperprolinemia Type I and II: These are rare autosomal recessive disorders. Type I is caused by a deficiency in proline oxidase, and Type II is caused by a deficiency in P5C dehydrogenase. Administering Proline to these patients can lead to neurotoxicity, seizures, and cognitive impairment because they cannot break down the amino acid.
2. 2Severe Hypersensitivity: Any history of anaphylaxis or severe systemic reaction to L-proline or any component of the amino acid injection (such as specific stabilizers or sulfites in some brands) is an absolute contraindication.
3. 3Inborn Errors of Amino Acid Metabolism: Beyond hyperprolinemia, conditions like certain urea cycle disorders where the body cannot process nitrogen safely make the use of any amino acid infusion extremely dangerous.

In these cases, a healthcare provider will perform a careful risk-benefit analysis:

• Severe Renal Failure (without dialysis): The inability to excrete nitrogenous waste (urea) means that amino acid administration could lead to rapid azotemia. If the patient is on hemodialysis, Proline may be used with caution.
• Hepatic Coma or Pre-coma: In severe liver failure, the brain becomes sensitive to nitrogen products. Adding Proline may worsen hepatic encephalopathy.
• Acute Heart Failure: The fluid volume required to deliver IV Proline may overwhelm a failing heart.
• Severe Acid-Base Imbalance: Patients with existing metabolic acidosis may have their condition worsened by the acidifying activity of certain amino acid formulations.

Patients who are sensitive to other imino acids or related compounds should be monitored closely. Additionally, some amino acid solutions contain sulfites as preservatives. Patients with a known 'sulfite sensitivity' (common in people with asthma) may experience life-threatening bronchospasm if given these specific formulations.

> Important: Your healthcare provider will evaluate your complete medical history before prescribing Proline.

FDA Pregnancy Category C

Animal reproduction studies have not been conducted with Proline infusions. It is also not known whether Proline can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. However, Proline is a naturally occurring amino acid required for fetal development.

Clinical Considerations

During pregnancy, the demand for amino acids increases to support the growth of the fetus and placenta. If a pregnant woman requires parenteral nutrition, Proline is considered a necessary component. However, healthcare providers must ensure that nitrogen levels are strictly monitored to avoid hyperammonemia, which can be toxic to the developing fetal brain. Use during pregnancy should only occur if clearly needed and under strict medical supervision.

Proline is a natural component of human breast milk. When administered at physiological doses, it is unlikely to pose a risk to the nursing infant. However, the safety of high-dose pharmaceutical Proline during breastfeeding has not been formally established. The decision to continue breastfeeding while receiving amino acid infusions should consider the clinical necessity of the mother's treatment and the potential for any metabolic changes in the milk.

Proline is vital for the growth of children, particularly for the development of skin and bone. In pediatric parenteral nutrition, Proline is included in specialized concentrations.

• Premature Infants: Extreme caution is required due to the risk of aluminum toxicity and the immaturity of the urea cycle enzymes.
• Monitoring: Children require more frequent monitoring of blood ammonia and BUN levels than adults.

Clinical studies of Proline-containing infusions have not identified significant differences in response between the elderly and younger patients. However, because elderly patients are more likely to have decreased renal function, the risk of nitrogen accumulation is higher.

• Dosing: Start at the lower end of the dosing range.
• Assessment: Regular evaluation of GFR (Glomerular Filtration Rate) is essential to prevent azotemia.

In patients with a GFR below 30 mL/min, the clearance of urea (the byproduct of Proline metabolism) is significantly reduced.

• Adjustment: Total daily protein/amino acid intake may be restricted to 0.6g/kg/day in non-dialysis patients.
• Dialysis: Patients on hemodialysis or peritoneal dialysis actually lose amino acids during the procedure and may require increased Proline supplementation to compensate for these losses.

For patients with Child-Pugh Class C (severe) hepatic impairment, the liver's ability to convert Proline to glutamate and eventually urea is compromised. This can lead to an accumulation of aromatic amino acids and a depletion of branched-chain amino acids, potentially triggering hepatic encephalopathy. Specialized 'Hepatamine' solutions with adjusted amino acid ratios may be used instead of standard Proline-containing mixtures.

> Important: Special populations require individualized medical assessment.

Proline acts as a fundamental structural precursor. Its primary molecular target is the procollagen polypeptide chain. Within the endoplasmic reticulum of fibroblasts, Proline residues are hydroxylated by the enzyme prolyl 4-hydroxylase. This reaction is unique because it requires molecular oxygen, ferrous iron (Fe2+), alpha-ketoglutarate, and ascorbic acid. The resulting hydroxyproline is essential for the interchain hydrogen bonding that stabilizes the collagen triple helix.

Furthermore, Proline can function as an osmolyte, helping cells maintain volume under osmotic stress. In its role as an Acidifying Activity [MoA], the metabolic breakdown of Proline can contribute to the generation of acidic intermediates, which is utilized in specific clinical formulations to maintain pH balance.

The pharmacodynamic effect of Proline is observed through Nitrogen Retention. When Proline is administered in the presence of adequate non-protein calories (carbohydrates and fats), it promotes an anabolic state, characterized by a decrease in urinary nitrogen excretion and an increase in lean body mass. The 'onset' of this effect is metabolic and occurs within hours of starting an infusion, though clinical improvements in wound healing or muscle mass may take days or weeks to manifest.

| Parameter | Value |

|---|---|

| Bioavailability | 100% (IV); ~70-90% (Oral) |

| Protein Binding | Minimal (circulates as free amino acid) |

| Half-life | 60 - 120 minutes |

| Tmax | 0.5 - 1.5 hours (Oral) |

| Metabolism | Hepatic/Renal (Proline Oxidase pathway) |

| Excretion | Renal (<2% unchanged) |

• Molecular Formula: C5H9NO2
• Molecular Weight: 115.13 g/mol
• Solubility: Highly soluble in water (approx. 162 g/100 mL at 25°C).
• Structure: A cyclic, non-polar amino acid containing a pyrrolidine ring. It is the only proteinogenic amino acid where the alpha-amino group is secondary.

Proline is classified as a Non-Essential Amino Acid. Within the USP and FDA framework, it is part of the Amino Acid [EPC] category. It is chemically related to other amino acids like Glutamate and Arginine but is functionally distinct due to its unique conformational rigidity provided by its cyclic structure.